본문 바로가기

Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: A meta-analysis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
피인용
Web of Science 26
JCR IF
JCR 2012 2.514
ISSN
1522-1946

저자

  1. Jang, Jae-Sik제1저자Department of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, South Korea
  2. Jin, Han-YoungDepartment of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, South Korea
  3. Seo, Jeong-SookDepartment of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, South Korea
  4. Yang, Tae-HyunDepartment of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, South Korea
  5. Kim, Dae-KyeongDepartment of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, South Korea
  6. Kim, Dong-SooDepartment of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, South Korea
  7. Cho, Kyoung-ImDepartment of Cardiology, Maryknoll Medical Center, South Korea
  8. 김보현Department of Internal Medicine, Pusan National University Hospital, South Korea
  9. 제형곤Department of Internal Medicine, Pusan National University, Yangsan Hospital, Beomeo-ri, South Korea
  10. 박용현교신저자Department of Internal Medicine, Pusan National University, Yangsan Hospital, Beomeo-ri, South Korea

초록

Objectives To assess whether different degrees of creatine kinase-myocardial band isoenzyme (CK-MB) elevation after percutaneous coronary intervention (PCI) affect the subsequent risk of death. Background While there is consensus that extensive cardiac enzyme elevation increase mortality significantly, there is uncertainty about the exact clinical impact of smaller CK-MB elevations after PCI. Methods The published literature was scanned by formal searches of electronic databases such as PubMed and MEDLINE from January 1999 to October 2011. Risk ratio (RR) was used as summary estimate. Results Ten studies have been included totaling 48,022 patients who underwent PCI (12,246 patients with CK-MB elevation and 35,776 patients without CK-MB elevation). Mean followup duration for each study ranged from 6 to 48 months. CK-MB elevation >1x the upper limit of normal (ULN) conferred a significant increase in the risk of mortality with an overall RR of 1.74 (95% confidence interval [CI], 1.42 to 2.13, P < 0.001). Compared with patients without CK-MB elevation, there was a dose-response relationship with RR for death being 1.48 (95% CI, 1.251.77, P < 0.001) with CK-MB elevation 1 to <3x ULN, 1.71 (95% CI, 1.232.37, P = 0.001) with CK-MB elevation 3 to 5x ULN, and 2.83 (95% CI, 1.984.04, P < 0.001) with CK-MB elevation 5x ULN. Conclusions Even a small increase in CK-MB levels after PCI is associated with significantly higher risk of late mortality. Monitoring cardiac enzymes after PCI may help predict the long term clinical outcome. (c) 2012 Wiley Periodicals, Inc.

키워드

myocardial infarctionembolizationpercutaneous coronary interventionMB ENZYME ELEVATIONDRUG-ELUTING STENTSLONG-TERM MORTALITYTROPONIN-ICK-MBINTRAVASCULAR ULTRASOUNDBIOCHEMICAL MARKERSCLINICAL EVENTSINFARCTIONIMPACT

식별자

WoS UID
000318160200015